Verisante Technology Inc. V.VRS

RE: RE: Sensitivity

[Jenser]

Since you mention the Core:Verisante Technology Inc. Announces Pilot Study Results for Lung Cancer Detection SystemJuly 6, 2011Conclusion: Adding point LRS analysis to WLB + AFB imaging has the ability to detect preneoplastic lesions in real time with high sensitivity and specificity. The use of LRS has great potential for substantially reducing the number of false-positive biopsies associated with WLB + AFB with very little reduction in the detection sensitivity."reducing the number of false-positive" and "very little reduction in the detection sensitivity"Think about it! That is almost as if you would say "we will save quite some money with this device but unfortunately a few more people will die.Reduction in sensitivity is an absolute no.